AbbVie | ABBV - Le Chiffre D'Affaires De Vente

Prix De L'Action
198.71
Variation Quotidienne
-2.24 -1.11%
Mensuellement
-4.09%
Annuel
6.80%
Q2 Prévisions
194.46




Ventes Changement Date
AbbVie USD 16.62B 840M 2025-12
Abbott USD 11.16B 300M 2026-03
ALKERMES USD 384.5M 9.7M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Infinity Pharmaceuticals USD 583K 148K 2023-06
J&J USD 24.1B 500M 2026-03
Medtronic USD 9B 39M 2026-01
Merck USD 16.4B 880M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.86B 50M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Zoetis USD 2.4B 0 2025-12